Dr. Cecil B. Pickett joins the GVK Biosciences Scientific Advisory Board
GVK Biosciences (GVK BIO) announced the appointment of Dr. Cecil B. Pickett as Scientific Advisor to the Board of Directors.

Cecil B. Pickett, Ph.D.
GVK Biosciences
Cecil B. Pickett, Ph.D. has served as President of Research and Development, and member of the Biogen Idec Board of Directors for three years (March 2006-October 2009). Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions at Schering-Plough Corporation. As the Senior Vice President & President, Schering-Plough Research Institute, Dr. Pickett helped bring several large and small molecule candidates into the Schering-Plough clinical development pipeline. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Company.
Dr. Pickett received his B.S. in Biology from California State University, Hayward, Calif., and his Ph.D. in Cell Biology from the University of California, Los Angeles (UCLA).
Dr. Pickett has served as a member of the U.S. Food and Drug Administration (FDA) Science Board, the Advisory Committee to the Director of the National Institutes of Health and The National Cancer Policy Board of the Institute of Medicine. He has served as a member of the National Academies Committee on Science, Engineering and Public Policy and a member of the Institute of Medicine Forum on Drug Discovery, Development and Translation. He also sits on the Board of Directors with Zimmer Holdings Inc, was elected to the Institute of Medicine of the National Academy of Sciences in 1993 and also is a member of The American Society for Cell Biology, American Society of Biochemistry & Molecular Biology, American Association for Cancer Research, and the American Association for the Advancement of Science.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

It all adds up: Study finds forever chemicals are more toxic as mixtures - Research also finds that PFOA and PFOS are major contributors to toxicity
Actelion's ponesimod successful in mid-stage trial in patients with plaque psoriasis - Ponesimod to proceed to Phase III clinical development in psoriasis

Agilent Technologies Belgium S.A./N.V. - Machelen (Diegem), Belgium
Mechanical heart valve prosthesis superior to biological
The Institute of Cancer Research - London, United Kingdom

The 2024 Balzan Prizes Focus on Sustainable Progress - From Law to the History of Science, and from the Biology of Ageing to Innovative Materials: 750,000 Swiss Francs will be awarded to each of the four winners of the Balzan Prizes
PANalytical becomes distributor for OBLF product line
UF discovery could lead to better genetic screening for diabetes

Unpacking asymmetric cell division

The carotenoid transfer between 2 proteins

Wacker Biotech B.V. - Amsterdam, Netherlands
